Cargando…
Non‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets
BACKGROUND: To date, standardising clinical predictive biomarkers for assessing the response to immunotherapy remains challenging due to variations in personal genetic signatures, tumour microenvironment complexities and epigenetic onco‐mechanisms. MAIN BODY: Early monitoring of key non‐coding RNA (...
Autores principales: | Alahdal, Murad, Elkord, Eyad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514379/ https://www.ncbi.nlm.nih.gov/pubmed/37735815 http://dx.doi.org/10.1002/ctm2.1425 |
Ejemplares similares
-
Role of exosomal ncRNAs released by M2 macrophages in tumor progression of gastrointestinal cancers
por: Meyiah, Abdo, et al.
Publicado: (2023) -
Promising use of immune cell‐derived exosomes in the treatment of SARS‐CoV‐2 infections
por: Alahdal, Murad, et al.
Publicado: (2022) -
Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities
por: Alahdal, Murad, et al.
Publicado: (2022) -
Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022) -
Exosomes: Biological Carriers and Promising Tools for Cancer Immunotherapy
por: Saleh, Reem, et al.
Publicado: (2020)